Tuberculosis profile
Population  2012 <1 million
Estimates of TB burden * 2012 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) <0.01 (<0.01–<0.01) 0.1 (0.02–0.24)
Mortality (HIV+TB only)        
Prevalence  (includes HIV+TB) <0.01 (<0.01–<0.01) 2.7 (0.81–5.7)
Incidence  (includes HIV+TB) <0.01 (<0.01–<0.01) 2.1 (1.8–2.4)
Incidence (HIV+TB only)        
Case detection, all forms (%)        
TB case notifications 2012        
New cases   (%) Retreatment cases (%)
Smear-positive     Relapse    
Smear-negative     Treatment after failure    
Smear-unknown / not done     Treatment after default    
Extrapulmonary     Other    
Total new     Total retreatment    
Other (history unknown)          
Total new and relapse     Total cases notified    
New cases Smear-positive Smear-negative/ unknown/
not done
M:F ratio      
Age < 15      
Laboratories 2012
Is second-line drug susceptibility testing available?  
Treatment success rate 2011 (%)        
New smear-positive and/or culture-positive     Is rifampicin used
throughout treatment for
new patients?
New smear-negative/extrapulmonary    
TB/HIV 2012 Number (%)
TB patients with known HIV status    
HIV-positive TB patients    
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT)    
HIV-positive TB patients on antiretroviral therapy (ART)    
HIV-positive people screened for TB    
HIV-positive people provided with IPT    
Estimates of MDR-TB burden 2012*   New   Retreatment
% of TB cases with MDR-TB 1.8 (0.9–2.6) 12 (9.2–15)
MDR-TB cases among notified pulmonary
TB cases
  (–)   (–)
Reported cases of MDR-TB 2012 New Retreatment Total
Cases tested for MDR-TB      
Laboratory-confirmed MDR-TB cases      
Patients started on MDR-TB treatment      
Financing TB control 2013
National TB programme budget (US$ millions)  
(Rate per 100 000 population per year)
Mortality graph
___ Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
___ Prevalence

(Rate per 100 000 population per year)
Incidence graph
__ Notifications Incidence
___ Incidence (HIV+TB only)

Treatment success rate (%)
tx success graph
__ New smear-positive and/or culture-positive
__ New smear-negative/extrapulmonary __

(Number of patients)
CPT ART graph
__ HIV-positive TB patients
__ on CPT __ on ART

 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 * Ranges represent uncertainty intervals Generated: 2014-04-16 Data: